Live-cell epigenome manipulation by synthetic histone acetylation catalyst system
- Proc Natl Acad Sci U S A. 2021 Jan 26;118(4):e2019554118. doi: 10.1073/pnas.2019554118.
- 1. Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo 113-0033, Japan.
- 2. Cell Biology Center, Institute of Innovative Research, Tokyo Institute of Technology, Yokohama 226-8503, Japan.
- 3. Institute for Quantitative Biosciences, The University of Tokyo, Tokyo 113-0033, Japan.
- 4. Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo 113-0033, Japan; [email protected] [email protected] [email protected].
Chemical modifications of histones, such as lysine acetylation and ubiquitination, play pivotal roles in epigenetic regulation of gene expression. Methods to alter the epigenome thus hold promise as tools for elucidating epigenetic mechanisms and as therapeutics. However, an entirely chemical method to introduce histone modifications in living cells without genetic manipulation is unprecedented. Here, we developed a chemical catalyst, PEG-LANA-DSSMe 11, that binds with nucleosome's acidic patch and promotes regioselective, synthetic histone acetylation at H2BK120 in living cells. The size of polyethylene glycol in the catalyst was a critical determinant for its in-cell metabolic stability, binding affinity to histones, and high activity. The synthetic acetylation promoted by 11 without genetic manipulation competed with and suppressed physiological H2B ubiquitination, a MARK regulating chromatin functions, such as transcription and DNA damage response. Thus, the chemical catalyst will be a useful tool to manipulate epigenome for unraveling epigenetic mechanisms in living cells.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: ADC LinkersResearch Areas: Others